BioSpace News Archive

NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, today announced its partnership with The Health Plan, a clinically driven, technology-enhanced and customer-focused health maintenance organization, to increase operating efficiency, lower costs and improve provider satisfaction via the full suite of NaviNet® Open Multi-Payer Portal applications.

Approach expected to have broad applications in agriculture, industrial biotechnology, human healthcare

If approved, Dupixent would be the first biologic medicine available in the U.S. for these children

Positive outlook for 2020: Sales revenue expected to rise 11% to 14% in constant currencies with further increase in profitability

Amplexor and Genpact announced that they are forming a strategic alliance where Genpact will provide enhanced Digital Transformation services to support Amplexor’s Regulatory Information Management solution.

Group sales revenue up 14.8%; order intake up 14.8%; underlying EBITDA margin 27.1%

Sera Prognostics, Inc. announced two podium presentations to take place at the Society for Maternal-Fetal Medicine’s 40th Annual Pregnancy Meeting in Grapevine, Texas, near Dallas, on February 3-8, 2020.

According to a researcher at Xi’an Jiaotong-Liverpool University, the Wuhan coronavirus, nCoV-2019, is closely related to SARS from the viewpoint of virus evolution.

The Feinstein Institutes for Medical Research President and CEO Kevin J. Tracey, MD, will present the New York Society for Neurosurgery (NYSN) 2020 Elsberg Lecture about the emerging field of bioelectronic medicine

Cerus Corporation (Nasdaq: CERS) announced today that it has commenced a registered underwritten public offering of $50.0 million of its common stock